TECENTRIQ

Brand name authorized in: Austria Australia Brazil Canada Cyprus Spain Finland France Hong Kong Ireland Lithuania Netherlands New Zealand Poland United Kingdom United States

Active ingredients

The drug TECENTRIQ contains one active pharmaceutical ingredient (API):

1 Atezolizumab
UNII 52CMI0WC3Y - ATEZOLIZUMAB

Atezolizumab is an Fc-engineered, humanised immunoglobulin G1 (IgG1) monoclonal antibody that directly binds to PD-L1 and provides a dual blockade of the PD-1 and B7.1 receptors, releasing PD-L1/PD-1 mediated inhibition of the immune response, including reactivating the antitumour immune response without inducing antibody-dependent cellular cytotoxicity.

Read about Atezolizumab

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
L01FF05
Atezolizumab
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FF PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
Discover more medicines within L01FF05

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
TECENTRIQ Concentrate for solution for infusion
Summary of Product Characteristics (SPC)

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 11277M, 11284X, 11297N, 11309F, 11792P, 11801D, 11802E, 11807K, 11926Q, 11927R, 11928T, 11929W, 11930X, 11931Y, 11940K, 11957H, 12076N, 12078Q, 12097Q, 12098R, 12155R, 12159Y, 12163E, 12164F, 12167J, 12168K, 12171N, 12174R
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 529218020027002, 529219110026507
CA
Health Products and Food Branch
Identifier(s): 02462990, 02492393
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 1171220001, 1171220001IP, 1171220002
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 494639, 533425
FR
Base de données publique des médicaments
Identifier(s): 60345905, 64422886
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 348083, 376167, 392553, 392555
HK
Department of Health Drug Office
Identifier(s): 65567, 66341, 66613
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1084155, 1088428
NL
Z-Index G-Standaard, PRK
Identifier(s): 148482, 199230
NZ
Medicines and Medical Devices Safety Authority
Identifier(s): 18470, 20388
PL
Rejestru Produktów Leczniczych
Identifier(s): 100395410, 100423803
SG
Health Sciences Authority
Identifier(s): 15425P
US
FDA, National Drug Code
Identifier(s): 50242-917, 50242-918